Perimeter Medical Imaging AI announces Q2 2026 earnings call for August 20, signaling continued financial transparency amid AI-driven medical tech growth
Executive summary: Perimeter Medical Imaging AI announced it will hold a conference call on August 20, 2026, to report its second quarter 2026 financial and operating results. The earnings call provides investors and stakeholders with updated performance data on a company commercializing AI-assisted surgical margin assessment tools, which are critical in oncology procedures.
Who is involved: Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTCQX: PYNKF), its executive leadership, and investors in the medical technology and AI healthcare sectors.
Likely next: The company will release its Q2 2026 financial results prior to the call, followed by the earnings conference call on August 20, after which analysts may issue updates on revenue, cash burn, and commercialization milestones.
Perimeter Medical Imaging AI, a commercial-stage medical technology company focused on AI-powered intraoperative imaging, has scheduled its second quarter 2026 financial results conference call for August 20. The announcement, made on August 13 via PR Newswire, follows a pattern of regular earnings disclosures by the company, which trades on the TSXV and OTCQX under ticker symbols PINK and PYNKF. While no financial figures were disclosed in the notice, the call will cover both financial and operating results for Q2 2026, offering investors insight into the company’s progress in commercializing its AI-enabled tissue imaging systems. The timing aligns with a broader trend of mid-August earnings releases across the medical technology and AI sectors.
Timeline
- — Perimeter Schedules Second Quarter 2026 Financial Results Conference Call for August 20th (PR Newswire)
Analysis — what this means
Likely next events
- Perimeter Medical Imaging AI to release Q2 2026 financial results before August 20, 2026
- Earnings conference call scheduled for August 20, 2026, after market close
Sectors affected
- Medical technology
- AI in healthcare
- Surgical imaging
Regulatory implications
- Continued compliance with SEC and TSXV disclosure requirements for quarterly reporting
- Ongoing adherence to FDA regulations for AI-based medical devices (Perimeter’s OCT-based systems are under regulatory review or clearance in key markets)
Sources
- Perimeter Schedules Second Quarter 2026 Financial Results Conference Call for August 20th — PR Newswire
Related cases
- Nuix launches generally available generative AI tools for legal review, signaling broader AI-driven efficiency gains in the legal tech market
- Fosun Pharma launches up to HK$1 billion H‑share buyback to bolster shareholder returns
- K-Royal Culture Festival Fall 2026 ticket sales open Sept 4, poised to boost cultural tourism revenue
- Acer’s Vero 16 launch signals a push toward repairable, AI-enhanced laptops that align with tightening environmental regulations
- Inturai Ventures completes acquisition of DomeCommand, an AI-driven command-and-control platform for autonomous drone swarms, expanding its defense-tech portfolio
- Retired teacher Janice Burnette launches third faith-based early-reader book, signaling sustained niche demand for scripture-based literacy materials